KR
34
-3
NWS
62
-2
USB
50
2
UPS
41
-4
DVA
72
2
VRSK
73
5
NWL
44
-4
TAP
58
-2
ORLY
53
-3
URI
53
-2
PDCO
35
-3
DHR
35
3
NOV
58
3
CAH
47
3
V
60
-6
BIIB
26
2
MCO
73
3
GIS
26
3
DHI
48
3
SYK
64
-4
KR
34
-3
NWS
62
-2
USB
50
2
UPS
41
-4
DVA
72
2
VRSK
73
5
NWL
44
-4
TAP
58
-2
ORLY
53
-3
URI
53
-2
PDCO
35
-3
DHR
35
3
NOV
58
3
CAH
47
3
V
60
-6
BIIB
26
2
MCO
73
3
GIS
26
3
DHI
48
3
SYK
64
-4
Financhill
Back

United Therapeutics Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
50

UTHR
United Therapeutics

Last Price:
364.59
Seasonality Move:
10.82%

7 Day Trial

ALL ACCESS PASS

$ 7

America's enemies are regrouping & it may sucker punch your savings

Click here to learn more.

United Therapeutics Price Quote

$364.59
+0.26 (+1.08%)
(Updated: November 21, 2024 at 5:29 AM ET)

United Therapeutics Key Stats

Sell
50
United Therapeutics (UTHR) is a Sell
Day range:
$359.40 - $365.67
52-week range:
$208.62 - $417.82
Dividend yield:
0%
P/E ratio:
18.13
P/S ratio:
6.37
P/B ratio:
2.63%
Volume:
192.4K
Avg. volume:
355.6K
1-year change:
59.1%
Market cap:
$16B
Revenue:
$2.3B
EPS:
$22.77

How Much Does United Therapeutics Make?

Is United Therapeutics Growing As A Company?

  • What Is United Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.23%
  • What Is United Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.19%

United Therapeutics Stock Price Performance

What Is United Therapeutics 52-Week High & Low?

United Therapeutics Price To Free Cash Flow

Is It Risky To Buy United Therapeutics?

Is United Therapeutics Cash Flow Positive?

  • What Is UTHR Cash Flow From Operations?
    Cash flow from operations (TTM) is $1.1B
  • What Is United Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$1.3B
  • What Is United Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $582.5M

United Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    UTHR return on invested capital is 17.45%
  • What Is United Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is 16.09%
  • What Is UTHR Return On Equity?
    ROE is a measure of profitability and is 19.26%

United Therapeutics Earnings Date & Stock Price

United Therapeutics Competitors

United Therapeutics Dividend Yield

United Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 18.77% -2.19%
Revenue: 22.89% 3.61%

Analyst Recommendations

Buy Recommendations: 7
Hold Recommendations: 5
Sell Recommendations: 1
Price Target: 382.29
Upside from Last Price: 4.93%

Major Shareholders

  • How many UTHR shares are owned by institutional investors?
    81.5M UTHR shares are owned by institutional investors
  • How many UTHR shares are owned by insiders?
    125.5K UTHR shares are owned by insiders